Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegfilgrastim to accelerate hematologic recovery after high-dose chemotherapy and autologous PBPC transplantation in Non-Hodgkin's lymphoma
2005-004442-14Phase 2Completed
- Sponsor
- University of Udine
- Start
- Nov 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pegfilgrastim in non-Hodgkin lymphoma (NHL), sponsored by University of Udine. Started Nov 2005; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on 2005-004442-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004442-14.